Hypertension
Long-term hypertensives often have other cardiovascular risk factors including elevated cholesterol levels, reduced Human hypertension is usually a slowly-developing high-density lipoproteins, diabetes, left ventricular hyperdisorder of middle to old age which predisposes to the trophy and obesity [2] . Untreated hypertensives present cardiovascular disorders that cause most of the morbidity acutely with stroke, coronary artery disease leading to and mortality in the elderly [2] . The incidence and myocardial infarction or acute renal failure. Most patients sequelae of hypertension vary markedly by patient subhave essential hypertension, where no cause can be group, particularly by gender and race [4] . The prevalence determined, which leads to many abnormalities in the of hypertension is higher in men than age-matched prephysiological regulatory systems for blood pressure includmenopausal women, but similar for 70-year-old men and ing neurotransmitters and humoral factors with abnorpostmenopausal women [4] . Physiological levels of oesmalities of the cardiac and vascular smooth muscle and trogen exert a cardioprotective effect, with postmenopausal endothelium. It is often unclear which of these changes are women being two to three times less likely to develop causative and which are secondary to the hypertension [6] . heart disease if receiving oestrogen replacement therapy These are the characteristics of human hypertension which [5] .
rat models should mimic. Many studies have been underHuman hypertension is probably triggered by environtaken using rat models of hypertension and heart failure mental influences such as increased salt intake, obesity and since an earlier comprehensive review [8] . Our review of lack of exercise acting on a genetic predisposition [6] . The hypertension is mainly of the rat models of systemic specific genes responsible for hypertension have not been hypertension, but some consideration of renal and pulmonidentified but epidemiological, family and twin studies ary hypertension is inevitable (Table 1) . Excessive vassuggest that a substantial portion of the phenotypic varioconstriction, commonly involving the endogenous pepation in blood pressure is genetically determined [7] .
tides, angiotensin II and endothelin, or deficient vasodilat- Table 1 Some rat models of hypertension, cardiac hypertrophy and failure ation, often involving nitric oxide (NO), are common pathophysiological basis for the observed linkages remain mechanisms in hypertension, whether defined as systemic, largely unknown. Another advantage of the SHR is that it pulmonary or renal.
follows the same progression of hypertension as human hypertension with pre-hypertensive, developing and sus-2.1. Systemic hypertension tained hypertensive phases with each phase lasting at least several weeks [22] . However the SHR differs from human 2.1.1. Spontaneously hypertensive and stroke-prone rats hypertension in that SHRs reproducibly develop hyperten-(SHRs and SHR-SP) sion in young adulthood rather than in middle age as in The most commonly used model of cardiovascular humans. Because SHRs have a pre-hypertensive state, they disease, with over 4000 Medline references in the last 10 have the important potential to be used in studies of the years, is the Spontaneously Hypertensive rat (SHR) often cause and development of hypertension. It is somewhat with the Wistar Kyoto rat (WKY) as the normotensive surprising that SHRs are rarely used for such studies. The control. SHRs are descendants of an outbred Wistar male SHR model is also suitable for gender studies in hypertenwith spontaneous hypertension from a colony in Kyoto, sion but only a few recent studies have considered gender Japan, mating with a female with an elevated blood differences in SHR responses [23, 24] . In addition, the pressure, and then brother3sister mating continued with normal life spans of normotensive and SHRs are comforselection for spontaneous hypertension, defined as a tably short, 2.5-3 years and 1.5-2.5 years, respectively, to systolic blood pressure of over 150 mm Hg persisting for make it relatively easy to follow 'cradle to grave' [25] . more than one month [9] . From 1968, this inbred strain of
The WKY controls were established later, in 1971, as a SHRs was further developed in the USA (reviewed in normotensive control strain by the National Institutes of [10] ). The various colonies of SHR are pre-hypertensive Health (USA) as an inbreed of the Wistar Kyoto colony via for the first 6-8 weeks of their lives with systolic blood brother3sister mating [10] . The degree of genetic differpressures around 100-120 mmHg [11] , and then hypertenence between the SHR and WKY strains and within sion develops over the next 12-14 weeks [12] . As in different colonies of each strain is substantial and comparhumans, hypertension develops more rapidly and becomes able to the maximum divergence possible between unremore severe in male than female SHR [13] . In vivo studies lated humans [26, 27] and thus unlikely to be related solely have shown that, in the early stages of hypertension, SHRs to hypertension. Differences between SHRs and Wistar have an increased cardiac output with normal total normotensive rats other than WKY may be more likely to peripheral resistance. As the SHR progresses into the be hypertension-related than differences between SHR and established hypertension state, the cardiac output returns to WKY because the SHRs were derived from the WKY, normal and the hypertrophied blood vessels produce an hypertension may develop spontaneously in the WKY, and increase in the total peripheral resistance [14] .
the WKY may share some of the genes responsible for The male SHR is commonly used as a model of hypertension with the SHR [28] . Significant established human hypertension, for example to define pathophysiological or pharmacological differences between hypertension-induced changes in signalling mechanisms SHR and normotensive rats may not be related to hy- [15] and to test new antihypertensive medication, for pertension but rather represent differences between various example felodipine [16] . Human hypertension is difficult colonies of normotensive rats [29] . to study as there is substantial individual variation in the The SHR is a useful model as compounds which lower two triggering elements of hypertension, polygenetic disblood pressure in SHR also lower blood pressure in position and excitatory environmental factors, leading to hypertensive humans. The SHR is a chronic stable model many variations in the direct and indirect effects on the producing symptoms which are predictable and controllcardiovascular system that are difficult to differentiate. able and avoiding difficult or life-threatening technical Researchers in hypertension have commonly resorted to interventions. Thus it is not surprising that SHRs have the use of SHRs which have, within each colony, uniform been used extensively and successfully for 30 years to test polygenetic disposition and excitatory factors which medicines for their effectiveness in lowering blood presproduce uniform changes in the indirect and direct effects sure, and to study the mechanisms of established hypertenon the cardiovascular system. This lack of inter-individual sion. The common criticism of the SHR model is that it variation is one of the major advantages of the SHR [17] has been around for a long time yet we still know little but it means that the SHR can only model one of many about the cause of the onset of hypertension. One reason is possible causes of human hypertension. As the specific that the appropriate studies with prehypertensive rats have genes responsible for developing hypertension have not not been done. Another reason is the difficulties in been identified, one of the most valuable contributions of undertaking and interpreting the appropriate genetic mapinbred genetic models is the mapping and identification of ping studies. these genes [7] . Extensive investigations have identified Experience with other genetic hypertensive strains of several quantitative trait loci for hypertension and diabetes rats has been limited by comparison with the SHR yet [18] [19] [20] [21] , although the identity of the genes and the these strains may be useful in determining the genes involved both in hypertension and in associated risk factors more severe in male than female DOCA-salt rats [44] . such as an elevated fibrinogen; some examples are the DOCA-salt rats have no signs of congestive heart failure New Zealand [30] , Milan [31] , Prague [32] , Lyon [33] and at 6 weeks (hepatic or pulmonary congestion or effusion; San Juan [34] hypertensive rats.
[41]). Initially there was about a 20% mortality associated with unilateral nephrectomy [41] but the mortality in our 2.1.2. Stroke-prone spontaneously hypertensive rat recent studies is around 1-2% within the first 4 weeks (SHR-SP) after surgery (Brown, unpublished observations). Hypertension is the major risk factor for stroke, a
The DOCA-salt model shows a markedly depressed cerebrovascular incident causing disability. Stroke in renin-angiotensin system and thus has been used in humans is uncommon under age 40 but increases markedly hypertension research as an angiotensin-independent model over age 65 with 65% due to atheroma and thrombosis, in the characterisation of new antihypertensive compounds 15% to haemorrhage and 15% to embolism [35] . The (for example, [45, 46] ). Mineralocorticoid overactivity, SHR-SP strain was developed following separation of the especially hypersecretion of deoxycorticosterone, is rarely SHR into three substrains, A, B and C, in 1971 with the A observed in humans [47] and is generally the result of a strain having a higher incidence of cerebrovascular disgenetic defect [48] . Although it may be more appropriate ease, followed by selective mating of offspring with at to administer aldosterone since this is the major minerleast one parent with spontaneous stroke [36] . The SHRalocorticoid in humans, an aldosterone-salt model has SP are hypertensive at 5 weeks and systolic blood pressure been less widely used than the DOCA-salt model although rises to at least 250 mmHg in males, in contrast to it produces similar responses [47, 49] . pressures of around 200 mmHg in SHR, with a positive Both the DOCA-and aldosterone-salt models rely on correlation between the incidence of cerebral lesions and impairment of kidney capacity and salt loading to rapidly blood pressure [36] . Salt-loading accelerates the developinduce hypertension and hypertrophy. This is not a very ment of hypertension and the occurrence of stroke [36, 37] .
realistic model for many human hypertensive patients: how The initial signs of stroke are excitement, hyperirritability, many have hypersecretion of aldosterone, one kidney and paroxysm, followed by behavioural and psychological eat huge amounts of salt to develop acute hypertension? depression and motion disturbances, apathy, coma and These models progress quickly to severe hypertension and death [36] . Consistent post-mortem findings are lesions in hypertrophy, and therefore are not suited for long-term the cortex or subcortex of the frontal, medial and occipital studies in chronic, stable disease. The model is econareas of the telencephalon with thromboses in the arterioles omical, with the technical requirements of this model around the lesions [36] . Since these lesions are similar to being such that, with experience, there should be minimal humans, SHR-SP have been used to investigate preventive mortality due to the procedures alone. strategies for both stroke (for example, mibefradil [37] or endothelin receptor blockade [38] ) and cardiac hypertrophy due to severe hypertension [39] . However, SHR-SP 2.1.4. NO synthase inhibition die in early to mid-adulthood (52-64 weeks [40] or around Nitric oxide (NO, endothelium-derived relaxing factor), 14-20 weeks old following salt-loading [37] ), in contrast a paracrine vasodilator, has been implicated in regulating to SHR (around 2 years), and WKY (around 3 years); thus vascular tone and myocardial contractility, and inhibiting this model does not mimic the most common age of onset platelet aggregation, and therefore may be critical in the of stroke in humans. Further, there is insufficient evidence development of hypertension and atherosclerosis [50] . that effective therapeutic regimes in the SHR-SP can be There are at least three forms of the NO synthase (NOS) translated into effective prevention of stroke in humans.
[51]; the cytokine-inducible NOS2 cosegregates with an No studies were found which used the SHR-SP to investiincreased blood pressure in the Dahl salt-sensitive rat [52] gate treatment regimens for stroke. but endothelial cell NOS3 seems uninvolved in human essential hypertension [53] . NO synthesis can be blocked
by inhibitors such as L-NAME (N -nitro-L-arginine methyl Salt retention is characteristic of human hypertension ester) and nitro-L-arginine. Chronic administration of Land can be achieved rapidly in uninephrectomised rats by NAME increased systolic blood pressure and heart weight mineralocorticoid administration, for example by weekly and decreased renal function; the ACE inhibitor ramipril subcutaneous injections of deoxycorticosterone acetate reversed all changes [54] . Chronic administration of L-(DOCA), and salt loading as 1% NaCl in the drinking NAME to rats during gestation induces the development of water [41] [42] [43] . Nephrectomised rats given deoxycorticoa pre-eclamptic syndrome similar to humans [55] . Since sterone or NaCl alone do not show any major changes in the role of decreased NO production in human hypertenblood pressure, and it is only the combination of deoxysion is unclear, it is too early to decide whether NO corticosterone and NaCl that produces a major increase in synthase inhibition is an appropriate model. However, this blood pressure with increases in cardiac and renal weight model deserves more attention as it is technically easy and [41]. Hypertension develops more quickly and becomes the procedure should have low mortality.
2.1.5. Transgenic rats stimulation of the renin-angiotensin-aldosterone system in Transgenic rats develop hypertension, hypertrophy and the absence of renal excretion or fluid loss. 2K2C hyheart failure, and are considered as models of hypertrophy pertension mimics bilateral renal artery stenosis in humans in this review.
while the clinical equivalent of the 1K1C model is unclear. Renovascular hypertension occurs in humans due to renal artery constriction, usually from atherosclerotic or 2.1.6. Diabetic hypertensive rats fibromuscular dysplastic renal disease, since this lowering Diabetes is an important risk factor in patients with of renal perfusion pressure causes the kidney to overhypertension and heart disease; further, diabetics have a produce renin and leads to a continual activation of the high incidence of cardiovascular disease, especially hyrenin-angiotensin-aldosterone system [69] similar to the pertension, atherosclerotic coronary disease, cartwo-kidney, one-clip (2K1C) model of hypertension. In diomyopathy and microvascular damage [56, 57] . Rapid contrast to 1K1C and 2K2C rats, 2K1C rats where the injection of streptozotocin to adult rats produces many of contralateral kidney remains untouched are a pressure the characteristic cardiovascular and renal features of overload model of hypertension as there is activation of the humans with uncontrolled insulin-dependent diabetes [58] , renin-angiotensin-aldosterone system and vasoconstriceven though these rats can survive without exogenous tion in the presence of renal excretion and fluid loss. These insulin for at least 12 weeks and are usually normotensive. models of renovascular hypertension cause a sudden Streptozotocin administration to SHR produces a model of increase in blood pressure, unlike the slow onset of human hypertensive insulin-dependent diabetic humans; these rats hypertension with the development of homeostatic mechashow progressive cardiac deterioration [59] and have been nisms. used to measure responses of antihypertensive drugs on
In the rat, 2K1C hypertension is characterised by sharp hypertrophy and vascular permeability [60] . Similar increases in plasma renin activity due to the decreased studies have been undertaken in the Cohen-Rosenthal renal arterial pressure in the clipped kidney, and increased diabetic hypertensive rat, a crossbreeding of the Cohen circulating angiotensin II concentrations and blood presdiabetic and SHR [61] . Since at least 85% of diabetics are sure within 2-4 weeks. Plasma renin activity and angiotennon-insulin-dependent with many of these patients being sin II levels return to near normal levels around 4 weeks hypertensive and obese, models of non-insulin-dependent with interstitial fibrosis now evident in the heart, especially diabetic hypertension are more relevant. The geneticallyaround the intramural coronary arteries. After several determined obese Zucker rat [59, 62, 63] fulfils the criteria months, a chronic phase develops characterised by eleas a relevant model of non-insulin-dependent diabetes [59] vated plasma renin activity and perivascular and interstitial with moderately elevated blood pressure, progressive fibrosis of the myocardium [70] . These results are broadly kidney damage [64] and hypercholesterolaemia. Lean, ageconsistent in rat and man [69] . 2K1C rats have been widely matched littermates are the appropriate control for the used as a high renin model of hypertension, for example in obese Zucker rat. A newer genetic model of human nonthe evaluation of angiotensin receptor antagonists [71] . insulin-dependent diabetes is the Otsuka Long-Evans
The 2K1C procedure in rats is not uniformly successful; Tokushima fatty rat which develops mild hypertension for example, of 105 rats, 19 did not develop hypertension, with typical cardiac and renal complications such as 27 developed malignant hypertension and 12 died; only 47 perivascular fibrosis and glomerulosclerosis [65] . Obesity (45%) developed stable hypertension [72] . appears to be an independent risk factor for cardiovascular Cardiac diseases remain the major cause of death in disease [66] ; the JCR:LA-cp rat is obese and develops patients with end-stage renal failure. The reduced renal atherosclerotic and myocardial lesions [67] . Further studies mass model of chronic uraemia in rats, produced by 5 / 6 are essential to determine the specific cardiovascular nephrectomy, is characterised by impaired cardiac function changes caused by chronic obesity, diabetes and mild after 28 days [73] as well as hypertension, cardiac hyhypertension.
pertrophy and fibrosis after 16 weeks which can be significantly improved by the ACE inhibitor, enalapril 2.2. Renovascular hypertension [74] . After 14 months of uraemia, the cardiac hypertrophy in these rats was not accompanied by a commensurate The kidney is vital in cardiovascular homeostasis yet increase in the number of capillaries [75] . This model renal damage is a relatively minor cause of human certainly allows the investigation of hypertension followhypertension. Renovascular hypertension develops in reing renal failure but it is hard to envisage the applicability sponse to renal ischaemia; models involve restricting blood to essential hypertension in humans. flow by clips on the renal arteries [68, 69] . The one-kidney,
The major cause of end-stage renal failure is insulinone clip model (1K1C), where one kidney is removed and dependent diabetes with hypertension being an additional a clip placed on the renal artery of the remaining kidney, risk factor. This can be reproduced in uni-nephrectomised and the corresponding two-kidney two-clip (2K2C) model rats with streptozotocin-induced diabetes; these rats deare volume overload forms of hypertension, as there is velop hypertension and renal failure within 8 months which can be improved by treatment with an ACE by prolonged exposure to normobaric hypoxia (for examinhibitor or an angiotensin AT1 receptor antagonist [76] .
ple, 2 weeks with 10% O , [89] ). Hypoxia in rats produces 2 Perinephretic hypertension, an unusual variant in characteristic morphological changes in the pulmonary humans, can be produced by encapsulation of one or both vasculature, especially an extension of smooth muscle into kidneys with a cellulose acetate wrap (cellophane wrap more peripheral pulmonary arteries and reduction in their model, [77] ). These rats develop left ventricular hypernumber [90] . The synthesis of the vasoconstrictor, endotrophy, reactive cardiac fibrosis and increased cardiac thelin, is increased and its actions on local ET receptors A stiffness [78] . Functional studies have not been reported in induces hypertension, vascular remodelling and right venthis model of hypertension. tricular hypertrophy [89] . The role of the endogenous vasodilator, NO, in hypoxia-induced pulmonary hypertension is unclear: both low NO due to hypoxia-induced 2.3. Pulmonary hypertension inhibition of uptake of its precursor, L-arginine [91] , and upregulation of endothelial NO synthase [92] have been In human pulmonary hypertension, pulmonary artery reported. systolic and mean pressures exceed 30 and 20 mm Hg, Right ventricular hypertrophy develops in humans living respectively, at rest or pulmonary artery mean pressure at high altitude. This has been simulated in rats in a exceeds 30 mm Hg during exercise [79] . Primary (unbarochamber, for example at 7000 m for 8 h / day, 5 days a explained) pulmonary hypertension is a rare but serious week for 24 exposures [93] or continuously for 14 days disorder that occurs predominantly (73%) in young women [94] . Rats subjected to hypobaric hypoxia develop pulmon-(mean age 34) who develop prominent central pulmonary ary hypertension and right ventricular hypertrophy with arteries and right ventricular hypertrophy followed by increased peak indices of mechanical performance [95] and failure. Survival is poor with only 21% surviving to 5 an increased collagen deposition partly reversible by years [80] . Secondary pulmonary hypertension is more enalapril treatment [93] . common and has many causes such as left ventricular Both monocrotaline treatment and hypoxia appear to systolic failure, chronic obstructive pulmonary disease, produce similar cardiac changes, especially selective right pulmonary thromboembolism and hypoventilation, and is ventricular hypertrophy, as in human pulmonary hypertencharacterised by swelling of the pulmonary capillary sion, although the pulmonary changes do not seem to be endothelial cells, thickening of endothelial cells basal comparable in rats and humans [96] . Since alveolar lamina and interstitial oedema [80] . The fundamental hypoxia is often the stimulant of the pulmonary vasoconmolecular mechanisms which may contribute to the pathostriction that underlies the hypertension in humans, the physiology of pulmonary hypertension have recently been hypoxia models probably better mimic the human disease. reviewed [81] .
These models fulfil the other criteria as useful models of human pulmonary hypertension.
Monocrotaline
Subcutaneous administration of a single dose of the Crotalaria alkaloid, monocrotaline (60-105 mg / kg), to rats 3. Cardiac hypertrophy and failure has been used as a non-invasive, slowly-developing, haemodynamically relevant model for primary pulmonary Cardiac hypertrophy is an increase in the mass of the hypertension leading to right ventricular hypertrophy contractile and ancillary proteins of the heart above that [82, 83] . Right ventricular performance was enhanced in which is normal for the given stage of its maturation monocrotaline-treated rats without heart failure, yet b -1 growth [97] . In its initial stages, the hypertrophied ventriadrenoceptor density and adenylate cyclase activity were cle is able to compensate in the face of an increased selectively decreased in the right ventricle [84] as were workload, but in the later stages, the diastolic and eventuisoprenaline-induced responses in isolated right ventricular ally the systolic properties of the left ventricle become myocytes [85] and noradrenaline-induced positive inoimpaired causing decompensation, and this leads to heart tropic responses in right ventricular papillary muscles [86] .
failure [97] . The commonest cause of cardiac hypertrophy Similar changes have been reported in the failing right is hypertension, and hypertrophy is an independent risk ventricle of patients with primary pulmonary hypertension factor for sudden death of unknown origin, and also [87] . The systemic effects of monocrotaline killed about increases the risk of myocardial ischaemia and of ventricu-20% of rats within the first few days [88] ; this experience lar arrhythmias [97] . does not appear to be general.
The common definition of heart failure is the inability of the heart to provide an adequate nutrient supply to 2.3.2. Hypoxia metabolising tissues [98] . Heart failure in humans can be Secondary pulmonary hypertension caused by hypoacute, for example immediately after a myocardial infarcventilation can be produced in rats as a model for humans tion, in hypertensive crises or in cardiotoxicity, but heart failure usually refers to the chronic condition following 4. Hypertrophy long-term hypertension or coronary heart disease [99] . Hypertension-induced heart failure is preceded by hy-4.1. Spontaneously hypertensive rats pertension-induced cardiac hypertrophy. Valvular heart disease and cardiomyopathy are also causes of chronic
The SHR is a commonly-used model of chronic hyheart failure. Left heart failure is the most common initial pertension (see above) which progresses to heart failure symptom and is associated with an increased pulmonary during the last six months of their lifespan of about 2 years capillary pressure which in turn causes an increase in the [107] . Thus, SHR should not be overlooked as a model to pulmonary venous system pressure to impair respiration study the mechanisms of hypertension-induced hyper- [100] . This progression is modified by reactive pulmonary trophy as it progresses to heart failure. Electrophysiologivasoconstriction and obliteration of small pulmonary arcal studies have shown that action potentials from hyteries which helps to decrease pulmonary capillary prespertrophied SHR left ventricular slabs or myocytes are sure and to protect the lungs from oedema but has the prolonged [108, 109] . Ion channel studies have shown disadvantage of causing an increase in pulmonary artery impaired function of cardiac inward rectifying K channels pressure (pulmonary hypertension) that ultimately causes without changes to transient or delayed outward rectifying right heart failure [100] . The heart responds to pressure K channels or L-type Ca channels in SHR hypertrophy overload by hypertrophy in the form of wall thickening [109] . Apoptosis is observed in the hearts of 8 and 16 and a reduced cavity size. In the hypertrophied heart, the week old SHRs [110] . Studies with multicellular SHR heart cells start to die and this myocyte necrosis is ventricular preparations usually show impaired contractiliassociated with fibroblast proliferation and expansion of ty and responses to b-adrenoceptor stimulation [108] the extracellular matrix. Programmed cell death (apoptosis) whereas hypertrophied SHR myocytes have increased rather than necrosis has been shown to be the key event in contractility [111] . end-stage human heart failure [101] [102] [103] . The heart is As hypertrophy in humans is usually associated with dilated in the final stages of heart failure [100] . This chronic hypertension, the SHR is a realistic model of chronic condition develops slowly in humans and is human hypertrophy. This model also fulfils the other associated with compensatory changes in other organs criteria in that it allows studies in chronic, stable disease, including the kidney, as well as in the peripheral vasculaproduces symptoms which are predictable and controllable, ture and skeletal muscle. In human heart failure, neuroand allows measurement of relevant cardiac, biochemical humoral systems become activated increasing the circulatand haemodynamic parameters. ing levels of noradrenaline, angiotensin, aldosterone and atriopeptin [98] .
4.2. Renal artery occlusion Reviews of animal models of heart failure [104] [105] [106] have all generally concluded that no one animal model can Renovascular hypertension resulting from renal ismimic entirely any one pattern of human heart failure. chaemia (see above) leads progressively to left ventricular Nevertheless many different models have been developed hypertrophy and failure. Hypertension in the adult heart and most are useful in evaluating particular aspects of induces concentric ventricular hypertrophy, in which wall failure (mechanisms in pathogenesis, drug intervention) thickness increases without chamber enlargement. This and can provide information not available in the clinic. The hypertrophy is characterised by a lateral increase in the choice of model, established or new, should be based on a size of the myocytes rather than an increase in the number particular question. Kept in perspective, and used in this of cells or average myocyte length [112] . About 12 weeks way, models complement clinical experience and extend after surgery, 2K1C rats show left ventricular heart failure our understanding of cardiovascular disease. Most humans with a 35% increase in left ventricular weight, increased with heart failure present in the later stages; thus models left ventricular end-diastolic pressure and wall stress with can be particularly useful as they allow study in the early reduced stroke volume and cardiac output together with stages.
marked ventricular fibrosis [113, 114] . In this review, we will consider whether some of the presently used rat models of heart hypertrophy and failure 4.3. Pressure loading by outflow constriction (Table 1) are appropriate as models of the human disease. We have chosen to emphasise models that attempt to Partial aortic constriction by aortic banding leads to a produce heart failure by hypertension and coronary artery rapid increase in cardiac load and therefore cardiac hydisease, the most common causes of human heart failure, pertrophy. Under anaesthesia, a left thoracotomy is perwhich occur together in 80% of patients with heart failure formed to expose the ascending aorta which is constricted [99] . The major problems with all heart failure models are to about 30% of the original cross-sectional area with a controlling the onset, rate of progression and degree of silver clip or a Week hemoclip [115] [116] [117] [118] . Alternatively, a heart failure, with particular difficulty in producing a stable spirally cut polyethylene catheter tube is placed around the level of failure.
abdominal aorta to produce the aortic stenosis [119] . The heart weight is increased by 47% in 28 days by banding studies of catecholamine-infused rats to determine whether [115] , and a low mortality of 10-15% is associated with these rats develop heart failure. the operation [115, 119] . This model has been used to Phaeochromocytomas produce very high catecholamine define the changes occurring during hypertrophy, for concentrations, usually much higher than in heart failure. example in cell size, myofibrils and myosin isoforms Thus, rats with this transplantable tumour may be a [120] , incidence of apoptosis [121] and altered adrenosuitable model for the pathological effects of chronic ceptor responsiveness [122] . There is no evidence of excess catecholamine concentrations but are unlikely to be chronic heart failure as liver enlargement or pleural or relevant for chronic heart failure research. These rats peritoneal effusions are not observed following short term develop cardiomyopathy and a functional desensitisation of banding [117] . However, superimposition of strepb-adrenoceptor function [131] but have not been further tozotocin-induced diabetes on the hypertension of abdomistudied as models of heart failure. nal aortic constriction led to ascites, liver and lung congestion and reduced heart noradrenaline levels as signs of heart failure [123] .
4.5. Transgenic rats Outflow constriction by aortic banding is clearly a model of cardiac hypertrophy and not of heart failure, Transgenic techniques are now increasingly used since although several of the above studies have suggested it is a they offer the possibility of analysing responses by selectmodel of heart failure. The operative procedure is relaed genes [132] . The most commonly used species for tively easy and has a high success rate in generating transgenic experiments is mice but their small size limits cardiac hypertrophy in a short time. This model does not their usefulness in cardiovascular research as few techmimic a clinical condition and one cannot be certain that niques are available for functional studies. Since the reninthe hypertrophy associated with this short sharp pressure angiotensin system is pivotal in controlling the caroverload is similar to that observed with the more gradual diovascular system, the murine Ren-2 gene was chosen to process of essential hypertension in humans.
generate transgenic rats [133] . Male rats have a sustained Right ventricular hypertrophy independent of pulmonary angiotensin II-dependent increase in blood pressure with hypertension can be produced by increasing right ventriculow circulating renin levels thus providing convincing lar pressure following pulmonary artery banding. In 7 evidence for the physiological significance of tissue reninweek old rats, banding to an internal diameter of 1.4 mm angiotensin systems. At 12-14 weeks, male transgenic rats for twelve weeks led to right ventricular hypertrophy and have concentric cardiac hypertrophy but no dilatation or an increased collagen fraction in the right ventricle [124] .
any signs of heart failure, and downregulation of b - This model would appear to mimic a minor cause of right adrenoceptors [134] . Female Ren-2 transgenic rats have ventricular dysfunction in humans.
been used to study the interplay between the renin-angiotensin system and oestrogen in the pathogenesis of 4.4. Catecholamines (isoprenaline and noradrenaline) hypertension [135, 136] . Since this transgenic rat line [TGR(mREN2)27] is a rat model of hypertension with a Heart failure is characterised by activation of the precisely defined monogenetic defect, it therefore cannot sympathetic nervous system leading to high circulating be considered as a genuine model of polygenic human noradrenaline concentrations which correlate with carhypertension [133] . Further, human hypertension is usually diovascular morbidity [125] . High noradrenaline concenassociated with normal or high plasma renin concentrations are associated with b-adrenoceptor downregulation trations. However, this model may allow a clearer under- [126] . Noradrenaline as the sympathetic neurotransmitter standing of the role of local renin-angiotensin systems in would seem to be the only relevant catecholamine for cardiovascular disease [137] . Transgenic rats expressing comparison with humans. Noradrenaline infusion leads to the human angiotensinogen gene have been used to test the selective left ventricular hypertrophy; cAMP-mediated functional importance of the local human renin-angiotenpositive inotropic responses were reduced in the hypersin system [138] . These results indicate that transgenic rats trophied left ventricle [127] . Unlike noradrenaline, isoare becoming an important tool in understanding hypertenprenaline is a nonselective b-adrenoceptor agonist producsion. ing no a-adrenoceptor-mediated vasoconstriction. The Angiotensin converting enzyme (ACE) produces the isoprenaline-infused rat has been used to study desensitizaphysiologically active peptide, angiotensin II. Local extion of the adenylate cyclase signalling pathway [128, 129] .
pression of ACE in the rat carotid artery [139] and of NO Isoprenaline-treated rats developed myocardial necrosis synthase in cardiomyocytes [140] were achieved using in and a progressive enlargement of the left ventricular cavity vivo gene transfer techniques. These techniques may out of proportion to mass, as in humans with discrete become important for defining the role of paracrine or myocardial infarction [130] . These studies have not meaautocrine substances in vascular biology and hypertension sured circulating noradrenaline or isoprenaline concenby making possible the comparison of segments with trations and therefore a comparison with levels in human overexpression of these factors and adjacent nontransfected heart failure is not possible. Further, there are no chronic vessel or muscle segments.
5. Heart failure fest hyperinsulinaemia and diabetes (males) or abnormal glucose tolerance (females). Obese rats develop fatal 5.1. Spontaneously hypertensive rats with failure dilated cardiomyopathy between 10 and 12 months (males) (SHRs-F) or 14 and 16 months (females) of age while lean male SHHF develop hypertension and left ventricular hyperThe SHR-F has been long known to have many simitrophy by 3 to 5 months of age and overt heart failure by larities to human essential hypertension-induced heart 16 to 20 months of age [146] [147] [148] . The circulating levels failure [141] including the important feature that impaired of noradrenaline, renin, aldosterone and atriopeptin are all myocardial performance is a late feature that precedes raised [146] and there are abnormalities in cardiac strucovert failure. More recently, Bing et al. [142] have shown ture such as biventricular hypertrophy, myocyte enlargethat at 18-24 months, 57% of the SHRs have cardiac ment and increased interstitial fibrosis [145] . Echocardiogdecompensation and they have further compared these raphy showed eccentric hypertrophy in 10-12 month old animals to age-matched SHR without failure (SHR-NF) non-failing male SHHF rats in contrast to the concentric and Wistar Kyoto normotensive (WKY) rats. The SHR-F hypertrophy in SHRs of the same age [149] . Expression of can be identified outwardly as they become less active and the genes for the enzymes controlling mitochondrial fatty well groomed and develop occasional tachypnoea which acid b-oxidation was reduced both in heart failure stages becomes more persistent and turns into laboured respiraof SHHF rats and in human heart failure [150] . tion. Left, but not right, ventricular hypertrophy is a feature
This model seems to have many similarities to the of the young adult SHR while hypertrophy of the right human disease when it is a slowly developing mix of ventricle is a reliable marker in the cardiac decompensahypertension, hyperinsulinemia and diabetes. The model tion of failure [142] . Pleuropericardial effusions and atrial needs to be more fully characterised but, because of its thrombi are also commonly observed in SHR-F. Echtime course, neurohumoral changes and lack of technical ocardiography was used to show that the SHR-F had intervention, has considerable potential as a model of the increased diastolic and systolic volumes and decreased development of human heart failure. The disadvantages of ejection fractions with cardiac catherization demonstrating this model are the variable expression of symptoms and an increased left ventricular end-diastolic pressure [142] .
expense as it is a slowly developing model, although Increased apoptosis of cardiomyocytes is observed in the age-induced changes should play a lesser role than in the SHR-F compared with the SHR-NF [143] which may be SHR-F. caused by increased endothelial cell NO synthase in cardiomyocytes [140] . The biochemical changes underly-5.3. Dahl /Rapp salt-sensitive rats ing the pathophysiology of heart failure are unclear; however, alterations in NO synthesis by myocardial NO Understanding salt-sensitive hypertension in humans has synthase have been implicated [144] .
been helped by the introduction of inbred rat models, The SHR-F model is a good model of human hyespecially the Dahl / Rapp salt-sensitive and salt-resistant pertension-induced heart failure as these conditions have rats [151] . The development of hypertension and heart many features in common, and thus will allow measurefailure in the Dahl / Rapp salt-sensitive rat can be conment of relevant cardiac, biochemical and haemodynamic trolled by titration of the amount of salt in their diet, and is parameters. In the SHR, failure occurs around 2 years of more rapid and greater in male than female rats [152] . age and may therefore be compromised by the effects of Addition of 8% NaCl to the diet at 6 weeks of age leads to ageing [142] . This may make the interpretation of the rat concentric left ventricular hypertrophy at 11 weeks, and data more difficult but it could also be argued that, since marked left ventricular dilation at 15-20 weeks which human heart failure is also commonly complicated by the leads to laboured respiration, left ventricular hypokinesis effects of ageing, the aged SHR is the more realistic and sudden death [153] . In human heart failure, specific model. As this is a non-intervention model, there is no organ (heart, lung, liver) enlargement is a feature and this need for skilled technical assistance or mortality associated is also observed in this salt-sensitive model of heart failure. with surgery. The major disadvantage of the SHR-F model
The isometric contractions of the isolated left papillary is the extended time frame and therefore increased costs of muscle of the Dahl / Rapp salt-sensitive rat heart are these experiments compared with other models of heart decreased and prolonged in the hypertrophied muscle and failure.
further decreased and prolonged in end-stage failure [153] . There is also a reduction followed by a loss in response of 5.2. Hypertensive HF-prone rats (SHHF) the left papillary muscle to isoprenaline in this model [153] . These contractile parameters are very similar to A hypertensive heart failure-prone rat strain, SHHF / those reported in end-stage human heart failure. The Mcc-cp or SHHF, that develops failure at a younger age corresponding normotensive control strain is the Dahl / than SHR was created by mating Koletsky rats heteroRapp salt-resistant rat; as with SHR and WKY rats, Dahl zygous for the corpulent gene with SHR [145] . These rats rats show more genetic polymorphism than expected [26] . are spontaneously hypertensive, 25% are obese and maniRecent studies have shown that modulation of NO pro-duction from L-arginine is integrally involved in the In their original report, Pfeffer et al.
[155] acknowldevelopment of hypertension in these salt-sensitive rats edged that coronary artery ligation was not analogous to [151, 154] .
the pathogenesis of coronary artery disease or to infarction Salt is considered to be one of environmental triggers in humans as the model initially contained an otherwise for human hypertension. However, the appropriateness of normal myocardium and coronary arteries. The inability of the model may be questioned as the parallel group of coronary artery ligation to model any common cause of humans who are as exquisitively salt-sensitive as the Dahl / heart failure is a major disadvantage. Other problems with Rapp salt-sensitive rat may be a subset of African-Amerithis model are the high mortality of the rats and the cans with inherited hypertension, salt sensitivity and a variation in infarct size, and that it does not have a predisposition to kidney damage [151] rather than a progression from compensation to endstage heart failure. significant proportion of hypertensive humans. The sympThese disadvantages are much less obvious following toms of the model do however have many characteristics coronary ligation in Lewis inbred rats in comparison with in common with the human disease. Other advantages are Sprague-Dawley rats [160] . The advantage to this model is that it is easy, non-invasive, relatively quick and conthat it quickly, and therefore economically, produces some sistent. This model is potentially useful in studies of the rats with some of the symptoms of heart failure. However, role of the L-arginine:NO pathway as a mechanism by we consider that the disadvantage of not modelling any which a well-compensated hypertrophied heart eventually cause of human heart failure far outweighs any advantages. decompensates.
Ischaemic heart disease in humans results from chronic non-occlusive coronary artery narrowing. This can be reproduced in rats by ligation of a probe held in contact 5.
Coronary artery ligation
with the left coronary artery and then removal of the probe resulting in an average 53% reduction in luminal diameter The most commonly used model of heart failure is and 43% mortality within 1 month [161]. The reduction in complete coronary artery occlusion by ligation. A left coronary blood flow leads to a predictable progression to thoracotomy is performed under ether anaesthesia; gentle impairment of left ventricular haemodynamic performance pressure on the right side of the thorax exteriorizes the and heart failure [162] . Although the major cause of the heart, and then the left coronary artery is ligated [155] . In chronic narrowing of human coronary arteries is atherothis initial and more recent studies (for example [156- sclerosis, usually of several vessels, rather than partial 158]), a high rate of mortality, up to 50%, occurred ligation, this model allows a slower, more realistic defollowing this drastic surgery. In Pfeffer's study, 46 of the velopment of ischaemic heart failure than complete corsurviving 90 rats at 3 weeks did not have signs of onary ligation. myocardial infarction at autopsy, and 44 had infarcts of 4-59% of the left ventricular endocardial circumference. This variation in infarct size observed after 3-4 weeks 5.5. Microembolization of coronary vessels usually results in the grouping of rats into a small infarct group, about 20% of the left ventricular circumference A more appropriate model of human heart failure may which is considered a model of myocardial infarction, and be produced by blockage of smaller intramyocardial a major infarct group, about 40-50%, which is considered vessels, for example by microspheres, rather than blockage the model of heart failure [156] [157] [158] . In their original of one of the larger epicardial coronary arteries. In the study, Pfeffer et al. [155] noted that the rats that had small anaesthetised rat, a catheter is placed into the left ventricle infarcts did not have outward signs of myocardial infarcby way of the external right carotid artery in order to tion and heart failure (no ascites, peripheral oedema, deliver a suspension containing about 150-200 000 plastic respiratory distress or failure to groom). There was also no microspheres of 15 mm diameter to the coronaries during a change in body weight or left ventricular weight and heart temporary occlusion of the ascending aorta [163] . The rate was normal but there was a gain in the weight of the embolized rats have a small decrease in heart rate, stroke right ventricle, an increase in ventricular and right atrial volume and cardiac index and an increase in total peripherpressures, and a decrease in arterial pressure. In those rats al resistance and left ventricular end-diastolic pressure with a large infarct, the right and left ventricle filling [163] . pressures were increased and cardiac output was decreased This model of heart failure is relatively new and only a after 3-4 weeks indicating that the rats were in failure preliminary characterisation has taken place. It seems [155, 156] . In these large infarct rats, there is hypertrophy likely that the model created by this technique will have of the septum but no weight gain of the left ventricle due similar characteristics, advantages and disadvantages to the to loss of viable myocardium [156] . Both necrosis and coronary ligation model, and in the absence of a diseased apoptosis are associated with the infarct in the coronary myocardium cannot be considered an appropriate model. It artery ligation model [159] . Large myocardial infarcts are would be of interest to compare mortality and variability also associated with increased circulating level of atriopepdata in both microembolization and coronary ligation tins and renin [158] . models.
5.6. Adriamycin (doxorubicin) disease characterized by the appearance of multinucleated giant cells in lesions. This disorder is not associated with The use of adriamycin in the treatment of human preceding infection and no pathogen has been isolated, and cancers is associated with the side effect of cardiotoxity thus it is presumed that autoimmune mechanisms are that can lead to congestive heart failure and death [164- involved. Myocarditis is frequently characterised by 166]. Rats treated with adriamycin are usually used to congestive heart failure and is occasionally lethal. Recently investigate the mechanisms of cardiotoxicity and ways of a new rat model of both acute and chronic heart failure preventing it [167] [168] [169] but occasionally used as a model following autoimmune myocarditis has been described in of heart failure [170] . Treatment of rats with adriamycin, 2 which the myosin fraction, extracted from the human heart mg / kg / week, for 12 weeks results in a decreased cardiac at autopsy from patients who had no history of myocarditis output, decreased blood pressure, pleural effusions, ascites or heart failure and no inflammatory lesions, is mixed with and hepatic congestion [170] . There is no change in heart Freund's adjuvant supplemented with Mycobacterium weight but there are pathological changes in the myocytes tuberculosis and injected subcutaneously into the foot pads such as cytoplasmic vacuolation, disorganisation of of Lewis rats [175] . In order to get a more effective myofibrils and some necrosis; adriamycin toxicity is not all sensitisation, Bordetella pertussis vaccine was also given as a result of cardiotoxicity, as anaemia, thrombocytosis i.v. [175] . This procedure does not produce myocarditis in and decreases in serum albumin are also observed [170] .
mice, guinea-pigs or other strains of rats. In the acute 21 of 41 rats did not survive the 12 week treatment with phase (after 4 weeks), there is massive pericardial effusion, adriamycin because of gross pathological changes conmild to moderate pleural effusion, gray swollen patch areas sistent with heart failure [170] .
on the cardiac surface, an increase in heart weight with The main advantages of this model is that it is a simple interstitial oedema and cellular infiltration, and inflammatechnique, non-invasive, economical and has a short time tion with the accumulation of neutrophils, lymphocytes course. It is an appropriate model of adriamycin cardiotoxand macrophages [175] . The chronic phase (after 3 icity but does not model any other type of heart failure. months) is characterized by diffuse myocardial fibrosis Thus this model is not useful in determining the mechawithout significant inflammation [176] . In vivo haemonisms or prevention of heart failure following decompensadynamic measurements have shown left ventricular tion following chronic hypertrophy.
systolic and diastolic dysfunction [176] . The inflammation and course of myocardial damage appear to be modulated 5.7. Alcoholic heart disease by cytokines and excessive amounts of NO produced by inducible NO synthase [177, 178] . This model has been Chronic ingestion of ethanol by humans is often associused in a study to evaluate the usefulness of cyclosporin, ated with alcoholic heart disease resulting in ventricular prednisolone and aspirin in the treatment of myocarditis dysfunction and heart failure; alcohol abuse may be a [179] . The advantage of this model of myocarditis is the major cause of cardiomyopathy [171] . Male rats mainproduction of severe symptoms unlike earlier models tained chronically on oral ethanol (30% in their drinking which gave mild lesions without congestive heart failure water for 8 months) developed myocardial damage, espe- [175] . This model is useful in evaluating the mechanisms cially multiple areas of myocyte loss and replacement and treatment of myocarditis but has little or no relevance fibrosis, and ventricular wall remodelling resulting in to heart failure of other etiologies. ventricular dysfunction; all necessary ingredients in the Chronic Chagas disease, produced decades after indevelopment of alcoholic heart disease [172] . Chronic fection with the parasite, Trypanosoma cruzi, is the leading ethanol treatment in rats produced moderate hypertrophy cause of heart failure in South and Central America. The with significantly decreased responses to phenylephrine, heart is the most commonly affected organ showing glucagon and dobutamine [173] . Short-term ethanol treatlymphocytic myocarditis, diffuse interstitial fibrosis and ment for 8 weeks produced no signs of heart failure but myocyte hypertrophy. These pathological changes were showed early decreases in a -adrenoceptor and muscarinic reproduced in rats chronically infected for 8 months with 1 receptor densities without any changes in b-adrenoceptor T. cruzi [180] . This model deserves further investigation density or adenylate cyclase activity [174] .
since adequate treatment of the symptoms of chronic This would seem to be an ideal model of alcoholic Chagas' disease would ameliorate this major public health cardiomyopathy demonstrating slowly-developing sympproblem in South America. toms similar to those in humans but, like the adriamycin model, would not be useful in determining the mechanisms 5.9. Pulmonary hypertension of the more common forms of heart failure due to either coronary artery disease or hypertension or both.
The monocrotaline model is commonly used as a model of pulmonary hypertension (see above) and occasionally 5.8. Myocarditis used as a model of heart failure. Right ventricular heart failure develops as accumulation of liquid in the peritoneal Giant cell myocarditis is a lethal inflammatory heart and pleural spaces in about 4 weeks after monocrotaline injection [88, 181, 182] ; at six weeks, heart failure is severe Aortacaval fistula procedures have a very high mortality with laboured respiration and often large volumes of fluid rate (77%, 133; 47% 134) but this is much reduced with in the chest [86] . Positive inotropic responses to noradthe revised procedure [189] to less than 5% [193] . Flaim et renaline but not calcium chloride are reduced six weeks al. [186] claim that aortacaval fistula is a form of heart after monocrotaline treatment [86] , as in human heart failure because it met the current definition as 'that failure [183] . However, several conditions not normally condition in which the heart is no longer able to pump an associated with human heart failure have been reported in adequate supply of blood in relation to the venous return monocrotaline-treated rats such as hepatic cirrhosis and and in relation to the metabolic needs of the body at the megalocytosis, venooclusive disease [182] and thromparticular moment'. They did however concede that the bocytopenia [184] . The major advantages are the ease and performance of these hearts is normal and that the prorapidity of producing the model. The disadvantages of the duction of aortacaval fistula was a model to study compenmonocrotaline model are the effects not associated with satory mechanisms associated with heart failure [186]. heart failure. As a model of one of the lesser causes of Most indexes of cardiac function were normal or elevated heart failure, the monocrotaline model may be useful in 5 months after surgery despite renal and hepatic congestion evaluating pharmacological interventions for pulmonary [188] although echocardiography showed abnormalities in hypertension-induced right heart failure, but it is hard to left ventricular filling at 18 weeks [194] . The combination see how this could be of benefit to the majority of patients of hypertension (SHR) and rats with aortacaval fistula did with heart failure associated with systemic hypertension not appear to be a relevant model of congestive heart and coronary artery disease. No studies of heart failure failure and provided no new concept or idea compared induced by chronic hypoxia in rats were found, although with aortacaval fistula in normotensive rats [190] . It seems this may be a relevant model of secondary pulmonary unlikely that the compensatory mechanisms following hypertension-induced failure.
aortacaval fistula mimic the compensatory mechanisms in human heart failure [186].
Aortacaval fistula (shunts)
Volume overloading produces cardiomegaly in humans [185] ; substantial volume overload-induced cardiac hy-6. Conclusions pertrophy can be produced in rats following large arteriovenous shunts. A mid-line incision is made in the Cardiovascular disease remains the major cause of death anaesthetised rat to expose the abdominal artery and vena in Western countries. The use of relevant models for cava, which are then isolated using bulldog clamps [186] .
human cardiovascular disease may provide useful inforUnder a dissection microscope, 1 mm openings are made mation allowing an understanding of the cause and proin each vessel and then the opposing edges are stitched gression of the disease state as well as potential therapeutic together. The clamps are removed and the patency of the interventions. The most common pathophysiological fistula is confirmed visually by the presence of mixing changes in the human cardiovascular system -hypertenarterial blood in the vena cava [186] . End-to-side anastomsion, cardiac hypertrophy and heart failure -have been oses between the left iliolumbar vein and the aorta successfully reproduced in rat models. There is an extenproduced shunts of about 1.25 mm diameter [187, 188] .
sive range of rat models; most mimic some aspects of the Similar shunts can be achieved by puncturing the aorta relevant human disease. No model mimics exactly all the with an 18 gauge needle, perforating its opposite wall and symptoms of the human disease, partly because many of penetrating the vena cava. The aorta is then clamped, the the changes in the human disease are not thoroughly needle taken out and a drop of cyanoacrylate glue used to understood, and this aim is probably illusory. As human seal the aorta puncture point [189] . Shunts have also been hypertension, hypertrophy and heart failure have many created in SHRs [190] . Aortacaval fistula below the renal different genetic and environmental causes, it may be arteries produced either compensated or decompensated appropriate to study different rat models. The major heart failure after 6 days with 35 or 65%, respectively, deficiency in many rat models is reproducing the slow increases in heart weight and all signs of heart failure such onset of human disease; important exceptions are the as ascites, oedema and dyspnoea [191] . Rats with aortacav-SHR-F and SHHF as models of heart failure. Several al fistula are a model of high cardiac output with decreased models do not reproduce the concurrent activation of mean arterial blood pressure, increased right atrial preshomeostatic mechanisms in humans, especially neurosure, increased left ventricular end-diastolic pressure and humoral changes during heart failure. Further, many rat marked hypertrophy of both ventricles with dilation of the models produce pathophysiological changes which are ventricular cavities [186] [187] [188] [189] . Ligation of the shunt led to rarely seen in the human disease state. However, a significant, but not complete, reversal of the cardiac thorough understanding of both the advantages and dishypertrophy showing that myocytes can remove recently advantages of each model is necessary if the results are to added series sarcomeres [192] .
be extrapolated to humans. This requires further studies on ogy and clinical consequences. J Cardiovasc Pharmacol both rats and humans and critical evaluation of the results 1993;22(Suppl 1):S1-S6.
of these investigations.
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